Success Metrics

Clinical Success Rate
90.6%

Based on 126 completed trials

Completion Rate
91%(126/139)
Active Trials
18(9%)
Results Posted
25%(32 trials)
Terminated
13(6%)

Phase Distribution

Ph early_phase_1
3
1%
Ph not_applicable
62
30%
Ph phase_2
38
18%
Ph phase_1
30
14%
Ph phase_4
35
17%
Ph phase_3
38
18%

Phase Distribution

33

Early Stage

38

Mid Stage

73

Late Stage

Phase Distribution206 total trials
Early Phase 1First-in-human
3(1.5%)
Phase 1Safety & dosage
30(14.6%)
Phase 2Efficacy & side effects
38(18.4%)
Phase 3Large-scale testing
38(18.4%)
Phase 4Post-market surveillance
35(17.0%)
N/ANon-phased studies
62(30.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.3%

126 of 146 finished

Non-Completion Rate

13.7%

20 ended early

Currently Active

18

trials recruiting

Total Trials

210

all time

Status Distribution
Active(22)
Completed(126)
Terminated(20)
Other(42)

Detailed Status

Completed126
unknown40
Terminated13
Recruiting11
Active, not recruiting7
Withdrawn7

Development Timeline

Analytics

Development Status

Total Trials
210
Active
18
Success Rate
90.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (1.5%)
Phase 130 (14.6%)
Phase 238 (18.4%)
Phase 338 (18.4%)
Phase 435 (17.0%)
N/A62 (30.1%)

Trials by Status

active_not_recruiting73%
completed12660%
terminated136%
withdrawn73%
unknown4019%
recruiting115%
not_yet_recruiting31%
suspended21%
enrolling_by_invitation10%

Recent Activity

Clinical Trials (210)

Showing 20 of 210 trialsScroll for more
NCT04065009Phase 3

The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer

Active Not Recruiting
NCT06789510Not Applicable

Treatment of Peyronie's Disease With Platelet-Rich Plasma

Completed
NCT07117955Not Applicable

Platelet-Rich Plasma for Peyronie's Disease

Recruiting
NCT06128382Phase 1

First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers

Completed
NCT07807449Phase 1

Safety and Preliminary Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Not Yet Recruiting
NCT06176248Not Applicable

Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis

Completed
NCT07029204Early Phase 1

Intralesional Cyclosporine for Alopecia Areata

Active Not Recruiting
NCT03063892Phase 4

Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

Active Not Recruiting
NCT04381299

Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?

Active Not Recruiting
NCT02279121Not Applicable

ATAPAC Study (TauroLock Activity in Adult Cancer Patients)

Completed
NCT03619538Not Applicable

Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery

Completed
NCT02702128Phase 3

Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery

Completed
NCT03304496Phase 4

Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.

Suspended
NCT07452822Phase 1

Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease

Not Yet Recruiting
NCT07440797Not Applicable

EVALUATION OF THE EFFICACY AND TOLERANCE OF VASHE SOLUTION VERSUS SALINE SOLUTION IN THE TREATMENT OF VENOUS OR MIXED LEG ULCERS PRESENTING INFLAMMATORY SIGNS SUGGESTING HEAVY BACTERIAL LOAD

Not Yet Recruiting
NCT06426550Not Applicable

Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV

Completed
NCT06077916Not Applicable

Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy

Completed
NCT06177197Not Applicable

Bronchiolitis Clearance Airways With Seaserum

Recruiting
NCT05569239Phase 2

Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg

Active Not Recruiting
NCT05324748Phase 3

Repeated GON Injections in CCH

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
210